Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I knew bad news was coming. A CEO does not sell his shares if he's not aware of forthcoming bad news. I got suckered in again at 1170, but so glad i sold at 1190.
This will definitely make new lows now. Sub 1000 ?
Sharecast News) - RBC Capital Markets initiated coverage of medical products manufacturer Smith & Nephew at 'outperform' on Wednesday with a 1,700p price target.
"The market is not pricing in the potential acceleration in both revenue growth and margins from the company's strong positioning in high-growth Sports Medicine and ASCs, as well as its differentiated CORI surgical robot and new cementless knee portfolio, in our view, as well as its operational improvement programme," RBC said.
"This provides an opportunity to build a position in a major med-tech company at a historically low entry point."